Mark For: ALBREC® trademark registration is intended to cover the categories of pharmaceutical preparations in the nature of recombinant human albuminous preparations for the treatment of hypovolemic shock, adult respiratory distress syndrome, major injury or surgery resulting in increased albumin loss or inadequate synthesis, acute nephrosis not responding to cyclophosphamide or steroid therapy, and acute liver failure or ascites where the therapeutic use is regulated by the individual circumstances; pharmaceutical preparations in the nature of recombinant human albuminous preparations as an adjunct in hemodialysis for patients undergoing long-term dialysis or for those patients who are fluid-overloaded and cannot tolerate substantial volumes of salt solution for therapy of shock or hypertension; pharmaceutical preparations in the nature of recombinant human albuminous preparations for the treatment of cardiac disease in cardiopulmonary bypass procedures; pharmaceutical preparations in the nature of recombinant human albuminous preparations in conjunction with exchange transfusion in the treatment of neonatal hyperbilirubinemia; pharmaceutical preparations in the nature of recombinant human albuminous preparations for use in the treatment of conditions in which there is severe hypoalbuminemia.
Status
2021-05-03 UTC
DEAD REGISTRATION Cancelled Invalidated
The trademark application was registered, but subsequently it was cancelled or invalidated and removed from the registry.
(Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use
No
Current Use
No
Intent To Use
No
Filed ITU
Yes
44D Filed
Yes
44E Current
Yes
66A Current
No
Current Basis
No
No Basis
No
Cancellation Code
2
Domestic Representative
Sarah Anne Keefe
Attorney Name
Sarah Anne Keefe
Attorney Docket Number
51713.0001.2
Law Office Assigned
M60
Employee Name
KIM, YONG OH
Timeline
2000-08-18
Application Filed
2003-09-02
Published
2003-09-02
Published for Opposition
2003-11-25
Trademark Registered
2008-01-18
Location: SCANNING ON DEMAND
2010-07-03
Cancelled
2010-07-03
Status: Dead/Cancelled
2010-07-03
Status: Registration cancelled because registrant did not file an acceptable declaration under Section 8. To view all documents in this
Sarah Anne Keefe Womble Carlyle Sandridge & Rice, PLLC P.O. Box 831 Raleigh NC 27602
Good, Services, and Codes
International Codes:
5
U.S. Codes:
006,018,044,046,051,052
Type Code
Type
GS0051
Pharmaceutical preparations in the nature of recombinant human albuminous preparations for the treatment of hypovolemic shock, adult respiratory distress syndrome, major injury or surgery resulting in increased albumin loss or inadequate synthesis, acute nephrosis not responding to cyclophosphamide or steroid therapy, and acute liver failure or ascites where the therapeutic use is regulated by the individual circumstances; pharmaceutical preparations in the nature of recombinant human albuminous preparations as an adjunct in hemodialysis for patients undergoing long-term dialysis or for those patients who are fluid-overloaded and cannot tolerate substantial volumes of salt solution for therapy of shock or hypertension; pharmaceutical preparations in the nature of recombinant human albuminous preparations for the treatment of cardiac disease in cardiopulmonary bypass procedures; pharmaceutical preparations in the nature of recombinant human albuminous preparations in conjunction with exchange transfusion in the treatment of neonatal hyperbilirubinemia; pharmaceutical preparations in the nature of recombinant human albuminous preparations for use in the treatment of conditions in which there is severe hypoalbuminemia
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.